FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

769129007: Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3690086014 Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3690087017 Triptorelin (as triptorelin acetate) 3.75 mg powder for suspension for injection syringe en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Is a Product containing triptorelin false Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has presentation strength numerator value 3.75 false Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has unit of presentation Syringe true Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has manufactured dose form Powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has basis of strength substance Triptorelin true Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has presentation strength denominator unit Syringe true Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has precise active ingredient Triptorelin acetate true Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Is a Product containing only triptorelin in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start